The Meclizine Hydrochloride Tablets, cataloged under National Stock Number 6505-01-100-5015, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Zenith Laboratories Inc. Government technical data includes 6 specifications, cited from the U.S. Government catalog. The record lists 7 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 7 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. 1 item shares a part number with this NSN in the catalog (possible match — not a government interchangeability claim). Current acquisition status: Active.
| Parameter | Value |
|---|---|
| NSN | 6505-01-100-5015 |
| Primary Part Number | NDC00172-2384-80 |
| Item Name | Meclizine Hydrochloride Tablets |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Zenith Laboratories Inc |
| Status | ACTIVE |
| Administration | ORAL |
| Primary Container Content Quantity | 1000.000 TABLETS |
| Supplementary Features | MEDSEP ITEM FOR DOD,AMERICAN CYANAMID CO,LEDERLE LABS DIV |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Type | BOTTLE |
| Active Medicament Medicinal Strength | 12.500 MILLIGRAMS MECLIZINE HYDROCHLORIDE ACTIVE INGREDIENT |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Part Number | Manufacturer |
|---|---|
| NDC00172-2384-80 PRIMARY | Zenith Laboratories Inc (USA) |
| NDC00182-0871-10 PRIMARY | Goldline Laboratories, Inc. Dba Goldline Laboratories (USA) |
| NDC00147-0137-20 PRIMARY | Procter & Gamble Pharmaceuticals, Inc. (USA) |
| NDC00662-2100-82 PRIMARY | Roerig Div Pfizer Inc (USA) |
| NDC00814-4645-30 PRIMARY | I D E Interstate Inc (USA) |
| NDC00904-2384-80 PRIMARY | Sidmak Laboratories Inc (USA) |
| NDC00223-1121-02 PRIMARY | Consolidated Midland Corp (USA) |
| Reference | Meaning |
|---|---|
| ANTIVERT | 5/1 Secondary reference Roerig Div Pfizer Inc |
| NDC00005-3140-34 | 5/9 Secondary reference American Cyanamid Co Lederle Laboratories Div |
| LEDERLE LABS | 5/1 Secondary reference U.S. Government activity |
| NDC47679-0294-04 | 5/9 Secondary reference Par Pharmaceutical Inc |
| ANTIVERT TABLETS | 5/1 Secondary reference Roerig Div Pfizer Inc |
| NDC00536-3986-10 | 5/9 Secondary reference Rugby Group Inc |
| NDC00781-1345-10 | 5/9 Secondary reference Geneva Pharmaceuticals Inc |
NSN 6505-01-100-5015 is a Meclizine Hydrochloride Tablets, manufactured by Zenith Laboratories Inc, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-100-5015 has 7 manufacturer part numbers on file: NDC00172-2384-80 (Zenith Laboratories Inc), NDC00182-0871-10 (Goldline Laboratories, Inc. Dba Goldline Laboratories), NDC00147-0137-20 (Procter & Gamble Pharmaceuticals, Inc.), NDC00662-2100-82 (Roerig Div Pfizer Inc), NDC00814-4645-30 (I D E Interstate Inc) and 2 more.
1 possible match (shared part number, not a government interchangeability claim): 6505-01-100-6478. Verify interchangeability with system specifications before substitution.
Key specifications for NDC00172-2384-80: Administration: ORAL; Primary Container Content Quantity: 1000.000 TABLETS; Supplementary Features: MEDSEP ITEM FOR DOD,AMERICAN CYANAMID CO,LEDERLE LABS DIV; Medical Designation and Grade: UNITED STATES PHARMACOPEIA. 6 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.